Z. Zhang

机构：AbbVie (United States) · ORCID：0000-0001-7037-5420

发表论文 11 篇 · 总被引 367 次 · h-index 7

代表论文

• Uteroglobin: a novel cytokine? (1999 · Cellular and Molecular Life Sciences · 被引 131)
• Optimality of group testing in the presence of misclassification (2011 · Biometrika · 被引 70)
• Real‐world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta‐analysis (2017 · Journal of Viral Hepatitis · 被引 57)
• Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration (2007 · Human Molecular Genetics · 被引 46)
• MRI Brain Volume Measurements in Infantile Neuronal Ceroid Lipofuscinosis (2016 · American Journal of Neuroradiology · 被引 31)
• Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials (2017 · Journal of Hepatology · 被引 18)